Latest Naloxone Stories
A nasal-spray version of Naloxone, a heroin/opiate overdose-reversal drug, is in the works in Kentucky. (PRWEB) June 06, 2014 As reported by USA Today
First and Only FDA-Approved Buccal Film Formulation of Buprenorphine and Naloxone to Compete in the $1.7 Billion and Growing U.S.
RICHMOND, Va., May 19, 2014 /PRNewswire/ -- Reckitt Benckiser Pharmaceuticals Inc. (RBP) announced today that it has entered into a definitive agreement with AntiOp, Inc.
BUNAVAIL PDUFA date June 7, 2014; Pre-launch activities underway to support an anticipated late Q3 2014 launch RALEIGH, N.C., May 8, 2014 /PRNewswire/ -- BioDelivery Sciences International,
Passages Malibu CEO comments on enhanced access to treatment in the US. Malibu, CA (PRWEB) May 06, 2014
The auto-injector is designed to allow quick administration when drug overdose first occurs. LOS ANGELES, CA (PRWEB) April 09, 2014 Family members and
The auto-injector is designed to allow quick administration when drug overdose first occurs LOS ANGELES, April 8, 2014 /PRNewswire/ -- Family members and caregivers of individuals
First presentation of detailed BUNAVAIL clinical data scheduled for April 11 and 13, 2014 RALEIGH, N.C., April 7, 2014 /PRNewswire/ -- BioDelivery Sciences International,
RICHMOND, Va., April 7, 2014 /PRNewswire/ -- Kaleo (formerly Intelliject) today announced that it has entered into a $150 million debt facility with PDL BioPharma (NASDAQ: PDLI) to enable kaleo to
First and only naloxone product specifically intended for emergency administration by family members or caregivers in settings where opioids may be present RICHMOND, Va., April 3, 2014 /PRNewswire/
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.